Answer
The most frequently reported adverse reactions to Livdelzi in clinical trials in patients with primary biliary cholangitis were headache, nausea, abdominal pain and abdominal distension, each occurring in more than 5% of patients.
Sources for this answer
- Livdelzi 10 mg capsulesGilead Sciences Ltd · emc · SmPC §4.8 Undesirable effects · Version 5Document updated
Sources checked